Managed Care Cast Presents: Challenges of Diagnosing and Managing PNH

Today we are bringing you a conversation between 3 experts on paroxysmal nocturnal hemoglobinuria (PNH).

Ryan Haumschild, PharmD, MS, MBA, vice president of Pharmacy at Emory Healthcare and Winship Cancer Institute, spoke with Jamie Koprivnikar, MD, of John Theurer Cancer Center; David Dingli, MD, PhD, of Mayo Clinic; and Brian P. Mulherin, MD, of American Oncology Network.

The topics of conversation for today’s podcast include the pathophysiology of PNH, complement inhibitors, treatment strategies, and the challenges of managing this rare, life-threatening disorder.

For the full conversation, watch the entire discussion.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify